Results 171 to 180 of about 8,827,264 (302)
Targeting KRAS for cancer therapy
In recent years, therapeutics targeted against KRAS proto‐oncogene GTPase (KRAS)‐mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of KRAS alterations at the lineage and allele levels, reviewing the clinical evidence for KRASG12C inhibition from the discovery of the recessive switch pocket to sotorasib ...
Jianlong Jia +4 more
wiley +1 more source
Antigen specificity and inflammatory amplification in autoimmune hepatitis. [PDF]
Xu Z, Liu Y, Zou H, Guo S.
europepmc +1 more source
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam +3 more
wiley +1 more source
Ovarian Cancer Nanovaccines: Recent Strategic Advances from Antigen Selection to Carrier Design. [PDF]
Tang X, Huang Y, Zhang X, He C.
europepmc +1 more source
Background and Purpose Degeneration of the pontine noradrenergic and midbrain dopaminergic systems contributes to cognitive‐behavioural disturbances during the prodromal stages of Alzheimer's disease (AD). We developed a genetically engineered, programmable probiotic Escherichia coli Nissle 1917 strain (EcNrhaL‐DOPA) capable of producing L‐3,4 ...
Mona Abdelhamid +9 more
wiley +1 more source
Identification of the HLA-DQB1*03:626 Allele in Two Individuals in a Western Indian Family. [PDF]
Parsaniya B +4 more
europepmc +1 more source
Koumine binds IGF2BP3 and promotes its proteasomal degradation, reducing m6A on EED mRNA, accelerating EED decay, lowering H3K27me3, and promoting IRF transcription, thereby restoring MHC‐I and enhancing CD8+ T cell killing. ABSTRACT Resistance to immune checkpoint blockade in gastric cancer often arises from defective antigen presentation due to MHC‐I
Qiu Hongqiang +10 more
wiley +1 more source
Improved access to kidney transplantation with favorable graft survival in highly sensitized candidates under the French acceptable mismatch program. [PDF]
Antoine C +7 more
europepmc +1 more source

